Skip to main content
SpringerLink
Log in

Kardiale Marker und körperliche Belastung

  • Chapter
Sportkardiologie

  • 2448 Accesses

Auszug

Körperliche Belastungen können zu Anstiegen von kardialen Markern führen, sodass differenzialdiagnostische Schwierigkeiten bei der Abgrenzung zwischen physiologischen belastungsinduzierten und krankhaften Aktivitäts- bzw. Konzentrationsänderungen auftreten können. Dies betrifft neben den Serumenzymen Kreatinkinase (CK), CK-MB, Laktatdehydrogenase (LDH), Glutamat-Oxalazetat- und Glutamat-Pyruvat-Transaminase (GOT und GPT) auch die kardialen Markerproteine Troponin I bzw. T und B-Typ Natriuretisches Peptid (BNP) bzw. NT-proBNP, die zur Diagnostik und Risikostratifizierung bei Patienten mit akutem Koronarsyndrom bzw. Myokardinfarkt und Herzinsuffizienz eingesetzt werden [3–6, 21, 26, 33, 44–46, 68]. Die belastungsinduzierten Veränderungen betreffen nicht nur Leistungssportler, sondern können auch bei gesunden Hobbysportlern oder Untrainierten durch langanhaltende, exzentrische oder ungewohnte köperliche Belastungen verursacht werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Alen M, Rahkila P, Marniemi J (1985) Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 6:139–144

    Article  PubMed  CAS  Google Scholar 

  2. Almeida S, Azevedo A, Castro A, Frioes F, Freitas J, Ferreira A, Bettencourt P (2002) B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes. Cardiology 98:113–115

    Article  PubMed  CAS  Google Scholar 

  3. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959–969

    Article  PubMed  CAS  Google Scholar 

  4. Apple F, Murakami M, Pearce L, Herzog C (2004) Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50:2279–2285

    Article  PubMed  CAS  Google Scholar 

  5. Apple F, Quist H, Doyle P, Otto A, Murakami M (2003) Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 49:1331–1336

    Article  PubMed  CAS  Google Scholar 

  6. Apple F, Wu A, Jaffe A (2002) European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144:981–986

    Article  PubMed  Google Scholar 

  7. Apple F, Quist H, Otto A, Mathews W, Murakami M (2002) Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 48:1097–1100

    PubMed  CAS  Google Scholar 

  8. Baxter G (2004) Natriuretic peptides and myocardial ischemia. Basic Res Cardiol 99:30–33

    Google Scholar 

  9. Berg A, Keul J (1979) Körperbelastung und Serumenzyme. Dtsch Z Sportmed 30:128–130

    CAS  Google Scholar 

  10. Bolli R und Marban E (1999) Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79:609–634

    PubMed  CAS  Google Scholar 

  11. Brunner-La Rocca H, Kaye D, Woods R, Hastings J, Esler M (2001) Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37:1221–1227

    Article  PubMed  CAS  Google Scholar 

  12. Burnett JJ (1999) Vasopeptidase inhibition: a new concept in blood pressure management. J Hypertens 17(Suppl):S37–S43

    CAS  Google Scholar 

  13. Chen Y, Serfass R, Mackey-Bojack S, Kelly K, Titus J, Apple F (2000) Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged exercise. J Appl Physiol 88:1749–1755

    PubMed  CAS  Google Scholar 

  14. Clarkson PM, Litchfield P, Graves J, Kirwan J, Byrnes WC (1985) Serum creatine kinase activity following forearm flexion isometric exercise. Eur J Appl Physiol Occup Physiol 53:368–371

    Article  PubMed  CAS  Google Scholar 

  15. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, Possemiers N, Wuyts FL, Vrints CJ (2004) Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 25:1797–1805

    Article  PubMed  CAS  Google Scholar 

  16. D’Souza S und Baxter G (2003) B Type natriuretic peptide: a good omen in myocardial ischaemia? Heart 89:707–709

    Article  PubMed  CAS  Google Scholar 

  17. D’Souza S, Yellon D, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter G (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284:H1592–1600

    PubMed  CAS  Google Scholar 

  18. Duarte JA, Magalhaes JF, Monteiro L, Almeida-Dias A, Soares JM, Appell HJ (1999) Exercise-induced signs of muscle overuse in children. Int J Sports Med 20:103–108

    Article  PubMed  CAS  Google Scholar 

  19. Filippatos G, Gangopadhyay N, Lalude O, Parameswaran N, Said S, Spielman W, Uhal B (2001) Regulation of apoptosis by vasoactive peptides. Am J Physiol Lung Cell Mol Physiol 281:L749–761

    PubMed  CAS  Google Scholar 

  20. Foote R, Pearlman J, Siegel A, Yeo K (2004) Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 16:1980–1987

    Article  CAS  Google Scholar 

  21. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA (2003) N-terminal probrain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24:1735–1743

    Article  PubMed  CAS  Google Scholar 

  22. George K, Whyte G, Stephenson C, Shave R, Dawson E, Edwards B, Gaze D, Collinson P (2004) Postexercise left ventricular function and cTnT in recreational marathon runners. Med Sci Sports Exerc 36:1709–1715

    Article  PubMed  Google Scholar 

  23. Gissel H, Clausen T (2001) Excitation-induced Ca2+ influx and skeletal muscle cell damage. Acta Physiol Scand 171:327–334

    Article  PubMed  CAS  Google Scholar 

  24. Hakkinen K und Alen M (1989) Training volume, androgen use and serum creatine kinase activity. Br J Sports Med 23:188–189

    PubMed  CAS  Google Scholar 

  25. Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257–260

    Article  PubMed  CAS  Google Scholar 

  26. Hamm C (2004) Leitlinien: Akutes Koronarsyndrom (ACS). Teil 1: ACS ohne persitierende ST-Hebung. Z Kardiol 93:72–90

    Article  PubMed  CAS  Google Scholar 

  27. Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W (2003) Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem 49:831–834

    Article  PubMed  CAS  Google Scholar 

  28. Hess G, Runkel S, Zdunek D, Hitzler WE (2005) Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): A study in blood donors. Clin Chim Acta 360:187–193

    Article  PubMed  CAS  Google Scholar 

  29. Hortobagyi T, Denahan T (1989) Variability in creatine kinase: methodological, exercise, and clinically related factors. Int J Sports Med 10:69–80

    PubMed  CAS  Google Scholar 

  30. Houben AJ, van der Zander K, de Leeuw PW (2005) Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 19:411–419

    Article  PubMed  CAS  Google Scholar 

  31. Huber KR, Mostafaie N, Bauer K, Worofka B, Kittl E, Hofmann J, Hejtman M, Redei K, Jungwirth S, Fischer P, Tragl KH (2004) Concentrations of N-terminal probrain natriuretic peptide and troponin T in plasma of 75-year-old apparently healthy persons. Clin Chem Lab Med 42:1430–1433

    Article  PubMed  CAS  Google Scholar 

  32. Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L (2005) NTProBNP in non-ST-elevation acute coronary syndrome. J Card Fail 11:S54–58

    Article  PubMed  CAS  Google Scholar 

  33. Jernberg T, Stridsberg M, Venge P, Lindahl B (2002) N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 40:437–445

    Article  PubMed  CAS  Google Scholar 

  34. Jonsdottir S, Andersen KK, Sigurosson AF, Sigurosson SB (2006) The effect of physical training in chronic heart failure. Eur J Heart Fail 8:97–101

    Article  PubMed  Google Scholar 

  35. Kindermann W, Sala-Fraire O, Sroka C, Müller U (1983) Serumenzymverhalten nach körperlicher Belastung-Abgrenzung von krankheitsbedingten Veränderungen. Herz/Kreisl 15:117–123

    CAS  Google Scholar 

  36. Koller A (2003) Exercise-induced increases in cardiac troponins and prothrombotic markers. Med Sci Sports Exerc 35:444–448

    Article  PubMed  CAS  Google Scholar 

  37. Koller A, Summer P, Moser H (1999) Regular exercise and subclinical myocardial injury during prolonged aerobic exercise. JAMA 282:1816

    Article  PubMed  CAS  Google Scholar 

  38. Konig D, Schumacher Y, Heinrich L, Schmid A, Berg A, Dickhuth H (2003) Myocardial stress after competitive exercise in professional road cyclists. Med Sci Sports Exerc 35:1679–1683

    Article  PubMed  Google Scholar 

  39. Korff S, Katus HA, Giannitsis E (2006) Differential diagnosis of elevated troponins. Heart 92:987–993

    Article  PubMed  CAS  Google Scholar 

  40. Krüger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U (2002) Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40:718–722

    Article  PubMed  Google Scholar 

  41. Kuhn M, Holtwick R, Baba H, Perriard J, Schmitz W, Ehler E (2002) Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart 87:368–374

    Article  PubMed  CAS  Google Scholar 

  42. Löffel M, Selzer N, Busch R, Edte S, Breidenbach T, von Hodenberg E (2005) BNP als Marker der Trainingssteuerung chronisch herzinsuffizienter Patienten. Dtsch Z Sportmed 56:208, PO Nr. 189

    Google Scholar 

  43. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel A (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction. Circulation 105:595–601

    Article  PubMed  CAS  Google Scholar 

  44. Luchner A, Holmer S, Schunkert H, Riegger G (2003) Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik. Dtsch Ärzteblatt 100:A3314–3321

    Google Scholar 

  45. Maisel A (2001) B-type natriuretic peptide levels: a potential novel „white count“ for congestive heart failure. J Card Fail 7:183–193

    Article  PubMed  CAS  Google Scholar 

  46. Maisel A, Krishnaswamy P, Nowak R, McCord J, Hollander J, Duc P, Omland T, Storrow A, Abraham W, Wu A, Clopton P, Steg P, Westheim A, Knudsen C, Perez A, Kazanegra R, Herrmann H, McCullough P (2002) Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure (Breathing Not Properly Multinational Study Investigators). N Engl J Med 347:161–167

    Article  PubMed  CAS  Google Scholar 

  47. Maron BJ, Tholakanahalli VN, Zenovich AG, Casey SA, Duprez D, Aeppli DM, Cohn JN (2004) Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109:984–989

    Article  PubMed  CAS  Google Scholar 

  48. McDonald C (1981) Enzyme levels after running. JAMA 246:40–41

    Article  PubMed  CAS  Google Scholar 

  49. McNeil P, Terasaki M (2001) Coping with the inevitable: how cells repair a torn surface membrane. Nat Cell Biol 3:E124–E129

    Article  PubMed  CAS  Google Scholar 

  50. Meyer T, Gabriel H, Auracher M, Scharhag J, Kindermann W (2003) Metabolic profile of 4 h cycling in the field with varying amounts of carbohydrate supply. Eur J Appl Physiol 88:431–437

    Article  PubMed  CAS  Google Scholar 

  51. Meyer T, Schwaab B, Gorge G, Scharhag J, Herrmann M, Kindermann W (2004) Can serum NT-proBNP detect changes of functional capacity in patients with chronic heart failure? Z Kardiol 93:540–545

    Article  PubMed  CAS  Google Scholar 

  52. Middleton N, Shave R, George K, Whyte G, Forster J, Oxborough D, Gaze D, Collinson P (2006) Novel application of flow propagation velocity and ischaemiamodified albumin in analysis of postexercise cardiac function in man. Exp Physiol 91:511–519

    Article  PubMed  CAS  Google Scholar 

  53. Mizuno Y, Yoshimura M, Harada E, Nakayama M, Sakamoto T, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Nakao K, Yasue H (2000) Plasma levels of A-and Btype natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 86:1036–1040, A11

    Article  PubMed  CAS  Google Scholar 

  54. Möllmann H, Nef H, Weber M, Hamm C, Elsässer A, Holubarsch C (2006) Ischämie ist ein unabhängiger Trigger für die BNP-Expression. Clin Res Cardiol 95(Suppl 7):P132

    Google Scholar 

  55. Montgomery H, Clarkson P, Dollery C, Prasad K, Losi M, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmund P, McEwan J, McKenna W, Humphries S (1997) Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741–747

    PubMed  CAS  Google Scholar 

  56. Mottram PM, Haluska BA, Marwick TH (2004) Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J 148:365–370

    Article  PubMed  CAS  Google Scholar 

  57. Mueller C, Laule-Kilian K, Christ A, Staub D (2005) The use of B-type natriuretic peptide in the diagnosis of acute dyspnoea. Clin Lab 51:5–9

    PubMed  CAS  Google Scholar 

  58. Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, Kubota T, Azuma A, Nishimura T (2002) Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 40:1657–1563

    Article  Google Scholar 

  59. Neumayr G, Gaenzer H, Pfister R, Sturm W, Schwarzacher S, Eibl G, Mitterbauer G, Hoertnagl H (2001) Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol 87:369–371

    Article  PubMed  CAS  Google Scholar 

  60. Neumayr G, Pfister R, Mitterbauer G, Eibl G, Hoertnagl H (2005) Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am J Cardiol 96:732–735

    Article  PubMed  CAS  Google Scholar 

  61. Neumayr N, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagel H (2002) Effect of the „Race across the Alps“ in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol 89:484–486

    Article  PubMed  CAS  Google Scholar 

  62. Newham DJ, Jones DA, Clarkson PM (1987) Repeated high-force eccentric exercise: effects on muscle pain and damage. J Appl Physiol 63:1381–1386

    PubMed  CAS  Google Scholar 

  63. Noakes TD (1987) Effect of exercise on serum enzyme activities in humans. Sports Med 4:245–267

    PubMed  CAS  Google Scholar 

  64. O’Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD (2000) Anabolic-androgenic steroids: medical assessment of present, past and potential users. Med J Aust 173:323–327

    PubMed  CAS  Google Scholar 

  65. Ohba H, Takada H, Musha H, Nagashima J, Mori N, Awaya T, Omiya K, Murayama M (2001) Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. Am Heart J 141:751–758

    Article  PubMed  CAS  Google Scholar 

  66. Passino C, Poletti R, Bramanti F, Prontera C, Clerico A, Emdin M (2006) Neurohormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. Eur J Heart Fail 8:46–53

    Article  PubMed  CAS  Google Scholar 

  67. Passino C, Severino S, Poletti R, Piepoli MF, Mammini C, Clerico A, Gabutti A, Nassi G, Emdin M (2006) Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47:1835–1839

    Article  PubMed  CAS  Google Scholar 

  68. Pfister R, Erdmann E, Schneider CA (2003) Natriuretic peptides BNP and NT-pro-BNP — The „new troponins“ for estimation of heart failure? Dtsch Med Wochenschr 128:1007–1012

    Article  PubMed  CAS  Google Scholar 

  69. Prusczyk P (2005) N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. J Card Fail 11(5 Suppl):S65–S69

    Article  CAS  Google Scholar 

  70. Raymond I, Groenning B, Hildebrandt P, Nilsson J, Baumann M, Trawinski J, Pedersen F (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89:745–751

    Article  PubMed  CAS  Google Scholar 

  71. Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett JJ (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976–982

    Article  PubMed  CAS  Google Scholar 

  72. Rifai N, Douglas P, O’Toole M, Rimm E, Ginsburg G (1999) Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol 83:1085–1089

    Article  PubMed  CAS  Google Scholar 

  73. Rogers MA, Stull GA, Apple FS (1985) Creatine kinase isoenzyme activities in men and women following a marathon race. Med Sci Sports Exerc 17:679–682

    Article  PubMed  CAS  Google Scholar 

  74. Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W (2005) Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150:1128–1134

    Article  PubMed  CAS  Google Scholar 

  75. Scharhag J, Herrmann M, Weissinger M, Herrmann W, Kindermann W (2007) Nterminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease. Clin Res Cardiol 96: im Druck

    Google Scholar 

  76. Scharhag J, Urhausen A, Herrmann M, Kindermann W (2003) Glück gehabt! Kasuistik eines 55-jährigen Marathonläufers mit koronarer Hauptstamm-und RIVAStenose. Dtsch Z Sportmed 4:118–121

    Google Scholar 

  77. Scharhag J, Urhausen A, Herrmann W, Schneider G, Kramann B, Herrmann W, Kindermann W (2004) No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete’s heart and healthy untrained controls. Heart 90:1055–1056

    Article  PubMed  CAS  Google Scholar 

  78. Scharhag J, Urhausen A, Schneider G, Herrmann M, Schumacher K, Haschke M, Krieg A, Meyer T, Herrmann W, Kindermann W (2006) Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide (NT-proBNP) in endurance athletes. Eur J Cardiovasc Prev Rehabil 13:388–397

    Article  PubMed  Google Scholar 

  79. Scharhag J und Kindermann W (2006) Brain natriuretic peptide (BNP) and exercise-induced immune reactions: Reply to the letter-to-the-editor of McLachlan and Mossop. Am Heart J 152:e3

    Article  CAS  Google Scholar 

  80. Shave R, Dawson E, Whyte G, George K, Ball D, Collinson P, Gaze D (2002) The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage. Med Sci Sports Exerc 34:651–654

    Article  PubMed  Google Scholar 

  81. Shave R, Dawson E, Whyte G, George K, Ball D, Gaze D, Collinson P (2002) Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race. Int J Sports Med 23:489–494

    Article  PubMed  CAS  Google Scholar 

  82. Shave R, Dawson E, Whyte G, George K, Gaze D, Collinson P (2004) Altered cardiac function and minimal cardiac damage during prolonged exercise. Med Sci Sports Exerc 36:1098–1103

    Article  PubMed  CAS  Google Scholar 

  83. Shave R, Dawson E, Whyte G, George K, Gaze D, Collinson P (2004) Effect of prolonged exercise in a hypoxic environment on cardiac function and cardiac troponin T. Br J Sports Med 38:86–88

    Article  PubMed  CAS  Google Scholar 

  84. Shave R, Whyte G, George K, Gaze D, Collinson P (2005) Prolonged exercise should be considered alongside typical symptoms of acute myocardial infarction when evaluating increases in cardiac troponin T. Heart 91:1219–1220

    Article  PubMed  CAS  Google Scholar 

  85. Siegel A, Lewandrowski E, Chun K, Sholar M, Fischman A, Lewandrowski K (2001) Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon. Am J Cardiol 88:920–923

    Article  PubMed  CAS  Google Scholar 

  86. Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, Mueller-Brand J, Perruchoud AP, Mueller C (2006) Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151:1223–1230

    Article  PubMed  CAS  Google Scholar 

  87. Stephenson C, McCarthy J, Vikelis E, Shave R, Whyte G, Gaze D, George K (2005) Effect of weightlifting upon left ventricular function and markers of cardiomyocyte damage. Ergonomics 48:1585–1593

    Article  PubMed  Google Scholar 

  88. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K et al (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97:4239–4244

    Article  PubMed  CAS  Google Scholar 

  89. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T (2000) Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23:776–780

    PubMed  CAS  Google Scholar 

  90. Toda G, Shibata S, Nakamizo R, Seto S, Yano K (2004) Effect of physical exercise training on health-related quality of life and exercise tolerance in patients with left ventricular dysfunction. J Cardiol 44:179–187

    PubMed  Google Scholar 

  91. Tulevski I, Hirsch A, Sanson B, Romkes H, van der Wall E, van Veldhuisen D, Buller H, Mulder B (2001) Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 86:1193–1196

    PubMed  CAS  Google Scholar 

  92. Tulloh L, Robinson D, Patel A, Ware A, Prendergast C, Sullivan D, Pressley L (2006) Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise — the Australian Ironman Triathlon. Br J Sports Med 40:605–609

    Article  PubMed  CAS  Google Scholar 

  93. Urhausen A, Albers T, Kindermann W (2003) Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. J Steroid Biochem Mol Biol 84:369–375

    Article  PubMed  CAS  Google Scholar 

  94. Urhausen A und Kindermann W (1999) Aktuelle Marker für Diagnostik von Überlastungszuständen in der Trainingspraxis. Dtsch Z Sportmed 51:226–233

    Google Scholar 

  95. Urhausen A, Kindermann W (1992) Biochemical Monitoring of Training. Clin J Sport Med 2:52–61

    Article  Google Scholar 

  96. Urhausen A, Scharhag J, Herrmann M, Kindermann W (2004) Clinical significance of increased cardiac troponin T and I in participants of ultra-endurance events. Am J Cardiol 94:696–698

    Article  PubMed  CAS  Google Scholar 

  97. Venditti P, Di Meo S (1996) Antioxidants, tissue damage, and endurance in trained and untrained young male rats. Arch Biochem Biophys 331:63–68

    Article  PubMed  CAS  Google Scholar 

  98. Vidotto C, Tschan H, Atamaniuk J, Pokan R, Bachl N, Muller MM (2005) Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes. Int J Sports Med 26:645–650

    Article  PubMed  CAS  Google Scholar 

  99. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Muller KD, Berkovitsch A, Mitrovic V, Hamm C (2004) N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148:612–620

    Article  PubMed  CAS  Google Scholar 

  100. Whyte G, George K, Sharma S, Lumley S, Gates P, Prasad K, McKenna W (2000) Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc 32:1067–1072

    Article  PubMed  CAS  Google Scholar 

  101. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, Fuchtbauer E, Dohrmann U, Beyersdorf F, Radicke D, Holubarsch C (2000) Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102:3074–3079

    PubMed  CAS  Google Scholar 

  102. Win HK, Chang SM, Raizner M, Shah G, Al Basky F, Desai U, Plana JC, Mahmarian JJ, Quinones MA, Zoghbi WA (2005) Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 150:695–700

    Article  PubMed  CAS  Google Scholar 

  103. Wu A, Feng Y (1998) Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 19Suppl N:N25–29.

    PubMed  CAS  Google Scholar 

  104. Yeo K, Lee H, Wong K, Foote R (2005) Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia? J Card Fail 11(5 Suppl):S59–64

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Sport- und Präventivmedizin, Universität des Saarlandes, Campus Gebäude B 8.2, 66123, Saarbrücken

    Dr. med. Jürgen Scharhag

  2. Centre de l’Appareil Locomoteur de Médecine du Sport et de Prévention, Centre Hospitalier de Luxembourg Clinique d’Eich, 78, rue d’Eich, 1460, Luxembourg

    Prof. Dr. med. Axel Urhausen

Authors
  1. Dr. med. Jürgen Scharhag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Axel Urhausen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Scharhag, J., Urhausen, A. (2007). Kardiale Marker und körperliche Belastung. In: Sportkardiologie. Steinkopff. https://doi.org/10.1007/978-3-7985-1707-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1707-3_6

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1706-6

  • Online ISBN: 978-3-7985-1707-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation